The global PET-CT scanner device market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2028, exhibiting a growth rate (CAGR) of 3.93% during 2023-2028.
Positron emission tomography (PET)-computed tomography (CT) scanner devices refer to medical equipment that examines and measures the metabolic activity of the tissues and cells of the body. They are commonly available in stationary, portable and mobile scanner variants. They consist of a machine with a round, donut-shaped hole in the middle and require a camera and a computer to evaluate tissue and organ functions. PET-CT scanner devices are widely used in cardiology, neurology and oncology departments to detect early signs of cancer, heart disease and brain disorders. They are non-invasive, accurate, painless and assist in increasing patient comfort and convenience. As a result, these devices are widely used in research institutes, hospitals and diagnostic centers.
PET-CT Scanner Device Market Trends:
The rising prevalence of chronic diseases across the world is creating a positive outlook for the market. PET-CT scanner device is widely used to measure body functions, such as glucose metabolism, oxygen usage and blood flow. Additionally, the widespread product utilization to diagnose gastrointestinal, endocrine, cancer, heart diseases and neurological disorders due to the increasing demand for better and reliable medical solutions and diagnoses is positively impacting the market growth. Moreover, various product innovations, such as the launch of portable scanner devices that offer increased mobility, shorter installation time, and decreased downtime, are providing an impetus to the market growth. Continuous product improvements are further assisting medical practitioners in recognizing unusual or irregular sites, classifying inflammatory injuries and identifying serendipitous anomalies. This, in turn, is favoring the market growth. Other factors, including rising in patient awareness regarding non-invasive procedures, increasing research and development (R&D) activities and significant improvements in healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global PET-CT scanner devicemarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, slice count, isotope and detector type, service provider and application.
Breakup by Type:
Portable Scanners/Mobile Scanners
Breakup by Slice Count:
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
Breakup by Isotope and Detector Type:
18 F Sodium Fluoride
Breakup by Service Provider:
Breakup by Application:
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bruker Corporation, Canon Medical Systems Usa Inc., General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Positron Corporation, Shimadzu Corporation, Siemens Healthcare GmbH (Siemens AG), Sofie Biosciences Inc., United Imaging Healthcare Co. Ltd. and Yangzhou Kindsway Biotech Co. Ltd.
Base Year of the Analysis
Type, Slice Count, Isotope and Detector Type, Service Provider, Application, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Bruker Corporation, Canon Medical Systems Usa Inc., General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Positron Corporation, Shimadzu Corporation, Siemens Healthcare GmbH (Siemens AG), Sofie Biosciences Inc., United Imaging Healthcare Co. Ltd. and Yangzhou Kindsway Biotech Co. Ltd.
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global PET-CT scanner device market was valued at US$ 2.2 Billion in 2022.
We expect the global PET-CT scanner device market to exhibit a CAGR of 3.93% during 2023-2028.
The rising adoption of PET-CT scanner devices in cardiology, neurology, and oncology departments to detect early signs of cancer, heart diseases, and brain disorders is primarily driving the global PET-CT scanner device market.
The sudden outbreak of the COVID-19 pandemic has led to the growing deployment of PET-CT scanner devices for the diagnosis, evaluation, and treatment of the coronavirus infection.
Based on the type, the global PET-CT scanner device market can be segmented into stationary scanners and portable scanners/mobile scanners. Currently, stationary scanners hold the majority of the total market share.
Based on the slice count, the global PET-CT scanner device market has been divided into low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). Among these, medium slice scanner (64 slices) exhibits a clear dominance in the market.
Based on the isotope and detector type, the global PET-CT scanner device market can be categorized into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F sodium fluoride, FMISO, gallium, thallium, and others. Currently, Flurodeoxyglucose (FDG) accounts for the majority of the global market share.
Based on the service provider, the global PET-CT scanner device market has been segregated into hospitals, diagnostic centers, and research institutes, where hospitals currently hold the largest market share.
Based on the application, the global PET-CT scanner device market can be bifurcated into oncology, neurology, cardiology, and others. Currently, oncology exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.
Some of the major players in the global PET-CT scanner device market include Bruker Corporation, Canon Medical Systems Usa Inc., General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Positron Corporation, Shimadzu Corporation, Siemens Healthcare GmbH (Siemens AG), Sofie Biosciences Inc., United Imaging Healthcare Co. Ltd., and Yangzhou Kindsway Biotech Co. Ltd.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.